51529-96-5

Usage

Uses

Used in Dye and Pigment Production:
4-ETHYL-3-NITROANILINE is used as a key intermediate in the production of various dyes and pigments, contributing to the coloration and stability of these products.
Used in Pharmaceutical Synthesis:
4-ETHYL-3-NITROANILINE is used as a building block in the synthesis of pharmaceuticals, playing a crucial role in the development of new drugs and medications.
Used in Agrochemical Production:
4-ETHYL-3-NITROANILINE is used as a component in the production of agrochemicals, such as pesticides and herbicides, to help protect crops and enhance agricultural productivity.
Safety Precautions:
Due to its hazardous nature, 4-ETHYL-3-NITROANILINE should be handled with care to prevent skin and eye irritation. It is also important to avoid ingestion or inhalation, and to follow proper storage and disposal procedures in accordance with local regulations to minimize potential health risks and environmental impact.

Upstream product

• 589-16-2 4-aminoethylbenzene 
• 3663-34-1 N-(4-ethylphenyl)acetamide 
• 5805-89-0 N-(4-ethyl-3-nitrophenyl)acetamide 
• 1204-29-1 1-ethyl-2,4-dinitrobenzene 
• 99-92-3 p-aminobenzophenone 

Downstream Products

• 5805-89-0 N-(4-ethyl-3-nitrophenyl)acetamide 
• 2001-16-3 4-chloro-1-ethyl-2-nitrobenzene 
• 10342-67-3 1-ethyl-4-iodo-2-nitrobenzene 
• 3843-97-8 2-ethyl-5-chloroaniline 
• 1090511-14-0 C₂₃H₂₀ClFO₂ 
• 1090511-04-8 C₂₂H₂₀Cl₂O₂ 
• 1090511-05-9 C₂₃H₂₃ClO₂ 
• 1090511-15-1 C₂₄H₂₃ClO₃ 
• 1090511-13-9 C₂₃H₂₃ClO₂ 
• 1090511-06-0 C₂₁H₂₀ClNO₂ 
• 1090511-01-5 C₂₂H₂₁ClO₂ 
• 1090511-07-1 C₂₀H₂₁NO₂S 
• 1090511-08-2 C₂₁H₂₁NO₃ 
• 1090511-11-7 C₁₉H₁₉ClN₂O₂ 

Relevant academic research and scientific papers

THIAZOLE DERIVATIVES USEFUL AS MUTANT IDH1 INHIBITORS FOR TREATING CANCER

A compound of Formula II or a pharmaceutically acceptable salt thereof, wherein CyN is a cyclic amine group bound via a nitrogen atom; X is C or N; R1 and R2 are each independently a halogen, CN, CF3, CHF2, CH2F, a C1-C10alkyl group, a C1-C10alkoxy group, a di(C1-C5alkyl)amino; m and n are each independently 1, 2, or 3, and represents either a single bond or a double bond, wherein the racemic mixture of 3-(4-(4-chlorophenyl)thiazol-2-yl)-1-(2-ethyl-5-methoxyphenyl)-6-(2-methylprop-1-en-1-yl)-5-(piperazine-1-carbonyl)pyridin-2(1H)-one atropisomers is excluded.

MUTANT IDH1 INHIBITORS USEFUL FOR TREATING CANCER

Compounds of Formula I and Formula II and the pharmaceutically acceptable salts thereof are disclosed The variables A, B, Y, Z, X1, X2, R1-4 and R13-18 are disclosed herein. The compounds are useful for treating cancer disorders, especially those involving mutant IDH1 enzymes. Pharmaceutical compositions containing compounds of Formula I or Formula II and methods of treatment comprising administering compounds of Formula I and Formula II are also disclosed.

SUBSTITUTED PYRROLES ACTIVE AS KINASES INHIBITORS

The present invention relates to substituted pyrrole compounds which modulate the activity of protein kinases and are therefore useful in treating diseases caused by dysregulated protein kinase activity, in particular Jak family kinases. The present invention also provides methods for preparing these compounds, pharmaceutical compositions comprising these compounds, and methods of treating diseases utilizing such compounds or the pharmaceutical compositions containing them.

PYRAZOLYL-PYRIMIDINE DERIVATIVES AS KINASE INHIBITORS

The present invention relates to pyrazolyl-pyrimidine derivatives which modulate the activity of protein kinases and are therefore useful in treating diseases caused by dysregulated protein kinase activity. The present invention also provides methods for preparing these compounds, pharmaceutical compositions comprising these compounds, and methods of treating diseases utilizing such compounds or the pharmaceutical compositions containing them.

PYRAZOLYL-PYRIMIDINE DERIVATIVES AS KINASE INHIBITORS

The present invention relates to pyrazolyl-pyrimidine derivatives which modulate the activity of protein kinases and are therefore useful in treating diseases caused by dysregulated protein kinase activity. The present invention also provides methods for preparing these compounds, pharmaceutical compositions comprising these compounds, and methods of treating diseases utilizing such compounds or the pharmaceutical compositions containing them.

SUBSTITUTED PYRIMIDINYL-PYRROLES ACTIVE AS KINASE INHIBITORS

The present invention relates to substituted pyrimidinyl-pyrrole compounds of formula (I) which modulate the activity of protein kinases and are therefore useful in treating diseases caused by dysregulated protein kinase activity, in particular Janus kinases. The present invention also provides methods for preparing these compounds, pharmaceutical compositions comprising these compounds, and methods of treating diseases utilizing such compounds or the pharmaceutical compositions containing them.

PYRAZOLO[1,5a]PYRIMIDINE DERIVATIVES AS IRAK4 MODULATORS

Compounds of the formula I or II: wherein X, m, Ar, R1 and R2 are as defined herein. The subject compounds are useful for treatment of IRAK-mediated conditions.

NOVEL HERBICIDES

Compounds of formula (I) wherein the substituents are as defined in claim 1, are suitable for use as herbicides.

NOVEL HERBICIDES

Compounds of formula (I) wherein the substituents are as defined in claim 1, are suitable for use as herbicides.

NOVEL HERBICIDES

Cyclohexanedione compounds, which are suitable for use as herbicides.